INCLINE VILLAGE, Nev.,
July 31, 2019 /PRNewswire/
-- PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI)
today announced that it will release its second quarter 2019
financial results for the period ended June
30, 2019, on Wednesday, August 7,
2019, after market close. PDL's management will host a
conference call and webcast that day at 4:30
p.m. Eastern time to discuss the operating and financial
results and recent developments. A slide presentation relating to
the call will be available via the webcast link on the PDL website
at http://www.pdl.com/.
Conference Call Details
To access the live conference
call via phone, please dial (844) 535-4071 from the United States and Canada or (706) 679-2458 internationally. The
conference ID is 9787426. Please dial in approximately 10
minutes prior to the start of the call. A telephone replay will be
available for one week following the call and may be accessed by
dialing (855) 859-2056 from the United
States and Canada or (404)
537-3406 internationally. The replay passcode is 9787426.
To access the live and subsequently archived webcast of the
conference call, go to the Company's website and go to "Events
& Presentations." Please connect to the website at least 15
minutes prior to the call to allow for any software download that
may be necessary.
About PDL BioPharma
PDL's mission is to improve the
lives of patients and create value for our shareholders and our
people by applying our capital and expertise for the successful
development and commercialization of innovative therapeutics by our
partner companies. We deliver on our mission by entering into
strategic transactions involving innovative late clinical-stage or
early commercial-stage therapeutics with attractive revenue growth
potential.
NOTE: PDL, PDL BioPharma, the PDL logo and the PDL
BioPharma logo are trademarks or registered trademarks of, and are
proprietary, to PDL BioPharma, Inc. which reserves all rights
therein.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-to-announce-second-quarter-2019-financial-results-on-august-7-2019-300892695.html
SOURCE PDL BioPharma, Inc.